Tumor / Cancer screening tests
This category includes tumor markers, sometimes called cancer markers, in the blood, urine, or body tissues. Tumor markers are substances made by cancer cells or by normal cells in response to cancer in the body. Some tumor markers are specific to one type of cancer. Others can be found in several types of cancers.
Tumor marker tests are most often used to:
- Plan your treatment. If tumor marker levels go down, it usually means the treatment is working.
- Help find out if a cancer has spread to other tissues
- Help predict the likely outcome or course of your disease
- Check to see if your cancer has come back after successful treatment
- Screen people at high risk for cancer.
Risk factors can include family history and previous diagnosis of another type of cancer.
Cancer screening tests also aim to find cancer early, before it causes symptoms and when it may be easier to treat successfully.
Effective screening tests are those that:
- Find cancer early
- Reduce the chance that someone who is screened regularly will die from the cancer
- Have more potential benefits than harms. (Possible harms of screening tests include bleeding or other physical damage, inaccurate test results, and overdiagnosis—the diagnosis of cancers that would not have caused problems and did not need treatment.)
------------------------------------------
Note: Can tumor markers be used in cancer screening?
Because tumor markers can be used to predict the response of a tumor to treatment and for prognosis, researchers have hoped that they might also be useful in screening tests that aim to detect cancer early, before there are any symptoms.
However, although tumor markers are extremely useful for determining whether a tumor is responding to treatment or assessing whether it has recurred, no tumor marker identified to date is sufficiently sensitive (that is, able to correctly identify people who have the disease) or specific (that is, able to correctly identify people who do not have the disease) to screen for cancer.
For example, until recently, the prostate-specific antigen (PSA) test, which measures the level of PSA in the blood, was used routinely to screen men for prostate cancer. However, an increased PSA level can be caused by benign prostate conditions as well as by prostate cancer, and most men with an elevated PSA level do not have prostate cancer. Because results from clinical trials showed that PSA testing leads at best to only a small reduction in the number of prostate cancer deaths and can lead to overdiagnosis and overtreatment, the PSA test is no longer recommended for routine screening. Now it is often used to monitor men with a history of prostate cancer to see if their cancer has come back. See the PSA Test fact sheet for more information.
Show more
Biomarkers included in this panel:
Other names: total AFP, alpha-fetoprotein-L3 Percent Healthy adults should have very low levels of AFP. AFP stands for alpha-fetoprotein. It is a protein made in the liver of a developing baby. AFP levels are usually high when a baby is born, b
Learn moreA CA 125 test may be used to monitor certain cancers during and after treatment. In some cases, a CA 125 test may be used to look for early signs of ovarian cancer in people with a very high risk of the disease.
Learn moreCancer antigen 15-3 (CA 15-3) is used to monitor response to breast cancer treatment and disease recurrence. The reference range of serum CA 15-3 is less than 30 U/mL. The upper limit of the range varies depending on the laboratory and kit used fo
Learn moreA CA 19-9 test measures the amount of a protein called CA 19-9 (cancer antigen 19-9) in a sample of your blood. CA 19-9 is a type of tumor marker. Tumor markers are substances made by cancer cells or by normal cells in response to cancer in your body
Learn moreCA 27.29
The cancer antigen 27.29 test (CA 27.29) is a blood test that measures the levels of glycoprotein produced by the mucin-1 (MUC1) gene. The level of CA 27.29, also known as 27.29, is used as a tumor marker to measure the activity of the disease in
Learn moreCA 72-4
Elevated CA72-4 levels in serum and plasma are seen in the pancreas, gallbladder, colon, cervix, and endometrium carcinomas. CA 72-4, also known as cancer antigen 72-4, is a protein that is commonly found in high levels in the blood of individuals
Learn moreCarcinoembryonic antigen (CEA) is a glycoprotein, which is present in normal mucosal cells but increased amounts are associated with adenocarcinoma, especially colorectal cancer. CEA therefore has a role as a tumour marker. Sensitivity and specificit
Learn moreThe CD19 antigen (aka B-lymphocyte antigen CD19 or Cluster of Differentiation 19) plays an important role in clinical oncology. It’s a protein found on the surface of B-cells, a type of white blood cell.
Learn moreChromogranin A (CgA)
Chromogranin-A (CgA) is an acidic glycoprotein expressed in the secretory granules of most normal and neoplastic neuroendocrine (NE) cell types, where it is released together with peptide hormones and biogenic amines. Neuroendocrine tumors (NETs) are
Learn moreThe CYFRA 21-1 is well known as tumor maker of lung cancer and is not influenced by environmental factors. CYRFA 21-1 (cytokeratin 19 fragment) has been demonstrated as clinically useful in the prognostication and monitoring of non-small cell lung
Learn moreThe Leukemia/Lymphoma/Myeloma Panel by Flow Cytometry is a specialized diagnostic test used in the field of hematology (=the study of blood and blood disorders) to analyze and classify various blood and bone marrow disorders, including: &rar
Learn moreMatrix Metalloproteinase 9 (MMP-9), also known as gelatinase B, is a critical enzyme in the human body that plays a vital role in remodeling the extracellular matrix, the network of proteins and other substances surrounding cells. It belongs to a lar
Learn moreMMP-9 is a marker of inflammation, tissue remodeling, wound healing, and mobilization of tissue-bound growth factors and cytokines. Matrix metalloproteinases (MMPs) play an important role in the progression of tumour cells and the invasion of infl
Learn moreNeuron-specific enolase (NSE) is a key biomarker predominantly found in neurons and neuroendocrine cells, making it highly valuable for clinical diagnostics and monitoring neurological and neuroendocrine disorders. NSE is a glycolytic enzyme that pla
Learn morePapIG, HPV, Rfx 16/18, refers to a series of tests used in cervical cancer screening. The Pap test, or Pap smear, is a procedure that collects cells from the cervix to detect precancerous or cancerous cell changes. HPV refers to the human papil
Learn moreTotal Prostate Specific Antigen (TPSA) is a serine protease produced by prostate cells, primarily used as a biomarker for the screening and monitoring of prostate cancer. While elevated TPSA levels can indicate the presence of prostate cancer, they c
Learn moreThe Prostate-specific antigen (PSA) test measures the amount of prostate specific antigen proteins made by the prostate gland and prostate cancers. It is used as a screen for prostate cancer, or a way to monitor progress of prostate cancer patients.
Learn moreThe free prostate-specific antigen test, known as the free PSA test, is used to help detect signs of prostate cancer. The test measures the level of unbound prostate-specific antigen in the blood, which can help doctors to diagnose issues like inflam
Learn moreS100
Total Prostate Specific Antigen (TPSA) is a serine protease produced by prostate cells, primarily used as a biomarker for the screening and monitoring of prostate cancer. While elevated TPSA levels can indicate the presence of prostate cancer, they c
Learn moreTumor Necrosis Factor-Alpha (TNF-α) is a critical biomarker used in medical diagnostics and research, known for its role in regulating inflammation and the immune system. A highly sensitive TNF-α test provides accurate detection of this c
Learn more